OPK (STOCKS)
Opko Health Inc.
$1.370000
-0.020000 (-1.44%)
Prev close: $1.390000
Company Information
- Exchange
- XNAS
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- CEO
- Phillip Frost
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,100.75M
- Employees
- 2,997
- P/E (TTM)
- -14.51
- P/B (TTM)
- 0.88
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.01 | $-0.08 | +0.0708 | +87.62% |
|
Mar 2026 (Q1)
|
$-0.07 | $-0.07 | +0.0007 | +0.99% |
|
Dec 2025 (Q4)
|
$-0.04 | $-0.07 | +0.0293 | +42.28% |
|
Sep 2025 (Q3)
|
$0.03 | $-0.05 | +0.0755 | +165.93% |
Financial Statements
| Revenues | $587.90M |
| Benefits Costs and Expenses | $362.13M |
| Cost Of Revenue | $348.20M |
| Costs And Expenses | $636.14M |
| Gross Profit | $239.69M |
| Nonoperating Income/Loss | -$31.58M |
| Operating Expenses | $474.14M |
| Selling, General, and Administrative Expenses | $205.85M |
| Research and Development | $125.22M |
| Operating Income/Loss | -$48.25M |
| Income/Loss Before Equity Method Investments | -$79.83M |
| Income/Loss From Continuing Operations After Tax | -$72.89M |
| Income/Loss From Continuing Operations Before Tax | $115.53M |
| Income/Loss From Equity Method Investments | -$22.00K |
| Income Tax Expense/Benefit | -$6.96M |
| Income Tax Expense/Benefit, Deferred | -$6.02M |
| Net Income/Loss | -$72.89M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$72.89M |
| Net Income/Loss Available To Common Stockholders, Basic | -$72.89M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.09 |
| Diluted Earnings Per Share | -$0.09 |
| Basic Average Shares | 1,539,213,440 |
| Diluted Average Shares | 1,541,977,891 |
| Assets | $1.83B |
| Current Assets | $500.24M |
| Inventory | $61.85M |
| Other Current Assets | $438.39M |
| Noncurrent Assets | $1.33B |
| Fixed Assets | $71.45M |
| Intangible Assets | $477.57M |
| Other Non-current Assets | $780.20M |
| Liabilities | $645.29M |
| Current Liabilities | $149.37M |
| Accounts Payable | $50.04M |
| Other Current Liabilities | $99.32M |
| Noncurrent Liabilities | $495.92M |
| Long-term Debt | $349.05M |
| Other Non-current Liabilities | $146.87M |
| Equity | $1.18B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.18B |
| Liabilities And Equity | $1.83B |
| Net Cash Flow From Operating Activities | -$123.38M |
| Net Cash Flow From Operating Activities, Continuing | -$123.38M |
| Net Cash Flow From Investing Activities | $206.34M |
| Net Cash Flow From Investing Activities, Continuing | $206.34M |
| Net Cash Flow From Financing Activities | -$52.73M |
| Net Cash Flow From Financing Activities, Continuing | -$52.73M |
| Net Cash Flow | $30.23M |
| Net Cash Flow, Continuing | $30.23M |
| Comprehensive Income/Loss | -$80.27M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$81.00M |
| Other Comprehensive Income/Loss | -$70.64M |
| Other Comprehensive Income/Loss Attributable To Parent | -$3.66M |